Insights

Gathering insights about Darmiyan…

Similar companies to Darmiyan

Darmiyan Tech Stack

Darmiyan uses 8 technology products and services including Webpack, Twemoji, Font Awesome, and more. Explore Darmiyan's tech stack below.

Webpack
Development
Twemoji
Font Scripts
Font Awesome
Font Scripts
React
Javascript Frameworks
imagesLoaded
Javascript Libraries
Lightbox
Javascript Libraries
WordPress Block Editor
Page Builders
Automattic
Platform As A Service

Media & News

Darmiyan, Inc. launched BrainSee Platform on Sep 16th '24.
SAN FRANCISCO, Sept. 16, 2024 /PRNewswire/ - Darmiyan, Inc., a pioneer in brain technology, is proud to announce the launch of the BrainSee Platform, integrating the first-of-its-kind FDA-approved BrainSee Test for Alzheimer's disease.
Sep 16, 2024 | www.prnewswire.com
Eisai invested into Darmiyan, Inc. $6M on Apr 1st '20.
In April, Darmiyan raised $6 million in seed funding from investors led by Japanese pharmaceutical company Eisai.
Sep 02, 2020 | medium.com
Darmiyan, Inc. received financing of $6M in Seed on Apr 1st '20.
Darmiyan, Inc., a San Francisco, CA-based developer of brain diagnostics, raised $6M in the initial closing of a seed funding.
Apr 10, 2020 | www.finsmes.com
Darmiyan, Inc. receives financing of $4.5M in equity financing and government grants.
Prior to the current funding round, Darmiyan had raised $4.5M in equity financing and government grants.
Sep 20, 2016 | www.prnewswire.com

Darmiyan's Email Address Formats

Darmiyan uses at least 1 format(s):

Darmiyan Email Formats	Example	Percentage
First@darmiyan.com	John@darmiyan.com	95%
FLast@darmiyan.com	JDoe@darmiyan.com	5%

Frequently Asked Questions

Where is Darmiyan's headquarters located?

Darmiyan's main headquarters is located at San Francisco, California United States. The company has employees across 4 continents, including North AmericaAsiaEurope.

What is Darmiyan's phone number?

You can contact Darmiyan's main corporate office by phone at

+1-515-270-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Darmiyan's official website and social media links?

Darmiyan's official website is darmiyan.com and has social profiles on LinkedIn Crunchbase.

What is Darmiyan's NAICS code?

Darmiyan's NAICS code is 92312 - Administration of Public Health Programs.

How many employees does Darmiyan have currently?

As of April 2026, Darmiyan has approximately 24 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Head Of Analytics And Innovation: E. K.Co-Founder: T. L.Business Development Lead, Turkey: A. R.. Explore Darmiyan's employee directory with LeadIQ.

What industry does Darmiyan belong to?

Darmiyan operates in the Public Health industry.

What technology does Darmiyan use?

Darmiyan's tech stack includes WebpackTwemojiFont AwesomeReactimagesLoadedLightboxWordPress Block EditorAutomattic.

What is Darmiyan's email format?

Darmiyan's email format typically follows the pattern of First@darmiyan.com. Find more Darmiyan email formats with LeadIQ.

When was Darmiyan founded?

Darmiyan was founded in 2016.

Darmiyan

Q: What is Darmiyan's official website and social media links?

Darmiyan's official website is darmiyan.com. Darmiyan has social profiles on LinkedIn.

Q: How many employees does Darmiyan have currently?

Darmiyan has approximately 24 employees.

Q: What technology does Darmiyan use?

Darmiyan's tech stack includes Elementor Header & Footer Builder, Python, Google Workspace, PHP, TweenMax.

Q: What is Darmiyan's NAICS code?

Darmiyan's NAICS code is 92312 (Administration of Public Health Programs).

Public HealthCalifornia, United States11-50 Employees

Darmiyan is a brain health technology company based in San Francisco, California, operating within the public health sector. It develops scalable tools for screening and monitoring brain health, designed to help clinicians assess cognitive conditions more accurately. The company focuses on enabling precise, personalized patient care through its products.

Its initial offering, BrainSee, has FDA approval and is available to physicians to assist in determining prognosis for patients diagnosed with amnestic mild cognitive impairment. In September 2024, Darmiyan introduced the BrainSee Platform, which brings together this FDA-approved test for use in Alzheimer's disease. The company’s primary customers are physicians and other healthcare providers seeking objective brain health assessments to inform care decisions.